THE JOHNS HOPKINS UNIVERSITYOFFICE OF NEWS AND INFORMATION3003 N. Charles Street, Suite 100Baltimore, Maryland 21218-3843Phone: (410) 516-7160 / Fax (410) 516-5251
DATE: February 25, 2003
TO: Reporters, producers and editors
RE: New contraceptive microbicide in clinical trials
Researchers at the Johns Hopkins University and ReProtect LLC have developed a gel for women that may both help block the spread of sexually transmitted diseases and reduce unwanted pregnancies.
The compound, known as BufferGel, is currently in advanced clinical trials for its ability to prevent pregnancy. Trials of its ability to block HIV transmission are scheduled to be under way soon.
When applied vaginally prior to intercourse, BufferGel maintains vaginal acidity at its normal levels, which can kill both sperm and many germs. A video news release on BufferGel is available online at:
http://www.jhu.edu/news_info/news/audio-video/buffergel.html
Copies of the videotape are available on request. An earlier news release on BufferGel is online at http://www.jhu.edu/news_info/news/home02/jan02/germs.html
RSS